Tumor necrosis factor alpha levels in plasma and whole-blood culture in dengue-infected patients: relationship between virus detection and pre-existing specific antibodies.
The pathogenesis of dengue hemorrhagic fever (DHF) is not well known, but the role of host factors has been suggested. The level of immunoreactive circulating and cell-generated tumor necrosis factor alpha (TNF alpha) was studied in 35 patients with DHF; its relationship with virus isolation and/or genome detection by reverse transcription polymerase chain reaction (RT-PCR) and specific antibodies were detected by hemagglutination inhibition (HI). Large variation of TNF alpha plasma levels was obtained in dengue-infected patients at the same stage of the disease and at the same day after infection. Most of the patients (14 out of 17 patients) who displayed augmented spontaneous in vitro production of TNF alpha by heparinized whole-blood culture compared with controls also had elevated levels of TNF alpha in the plasma. The TNF alpha values in lipopolysaccharide and phytohemagglutinin heparinized whole-blood cultures were not higher in patients than in controls, but low TNF alpha levels were obtained in three out of 30 patients. An inverse correlation was observed between spontaneous in vitro TNF alpha production and viral replication, which raises the issue of the antiviral effect of TNF alpha in dengue infection. The results do not support the hypothesis of the role of antibody-dependent enhancement giving rise to increased viremic titers and production of TNF alpha in patients. The present study demonstrates the activation of the TNF alpha-producing cells in dengue-infected patients and suggests further investigation to define the mechanism and the role of TNF alpha in the pathogenesis of dengue virus infection.
Hober
D
D
Laboratoire de Virologie, CHU, Lille, France.
Nguyen
T L
TL
Shen
L
L
Ha
D Q
DQ
Huong
V T
VT
Benyoucef
S
S
Nguyen
T H
TH
Bui
T M
TM
Loan
H K
HK
Le
B L
BL
Bouzidi
A
A
De Groote
D
D
Drouet
M T
MT
Deubel
V
V
Wattré
P
P
D000293:Adolescent; D000914:Antibodies, Viral / Q000096:biosynthesis / Q000097:blood*; D000918:Antibody Specificity; D002648:Child; D002675:Child, Preschool; D003715:Dengue / Q000097:blood* / Q000821:virology*; D005416:Flavivirus / Q000254:growth & development / Q000276:immunology* / Q000302:isolation & purification*; D005500:Follow-Up Studies; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000378:metabolism*
D000914:Antibodies, Viral; D014409:Tumor Necrosis Factor-alpha